Market Overview:
The global oxymetazoline market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of nasal allergies and sinusitis, rising awareness about the benefits of oxymetazoline products, and growing demand for over-the-counter (OTC) drugs. However, patent expirations of certain key products is expected to restrain the growth of this market during the forecast period. Based on type, the global oxymetazoline market can be segmented into spray and cream formulations. The spray formulation segment is expected to account for a larger share than the cream formulation segment in 2018 owing to its ease of use and high efficacy levels. Based on application, this market can be divided into rhinitis, sinusitis, nasal polyps, and other applications such as ophthalmology and pediatrics. Rhinitis is estimated to account for a major share in 2018 owing to its high prevalence across all regions studied in this research study.
Product Definition:
Oxymetazoline is a drug used as a nasal decongestant. It is a member of the sympathomimetic amine family, which works by constricting blood vessels in the nose. This reduces swelling and congestion.
Spray:
Spray is a fine mist that is usually applied to the skin. It's major usage includes treating Athletes Foot, Jock itch, Ringworm and other fungal infections of the skin. It also finds its use in treating various types of wounds including cuts, abrasions & burns. Spray can be directly applied to the affected area or can be used with soap or water for better results.
Cream:
Cream is a topical medication used for the relief of itching caused by skin diseases such as atopic dermatitis, psoriasis, and eczema. It also finds use in the treatment of other conditions such as scabies (lice) and warts. Creams are available in various forms including gels, ointments, lotions, creams & amp; liquids.
Application Insights:
The other application segment includes nasal congestion, rhinitis, and sinusitis. The others segment held the largest market share of over 70% in 2017 owing to its extensive use as an effective treatment for various nasal disorders. It works by relaxing the muscles in the nose and widening the blood vessels near the skin surface, which leads to increased blood flow and reduced inflammation. This medication is available in different forms such as spray, ointment, plugging drops for ears & eyes with oxymetazoline HCI 0.25%, 0.5%, 1%.
Oxymetazoline topical solution is used for treating nasal congestion due to a cold or flu virus or allergies that cause runny noses and sneezing fits throughout winter season especially during December-February period every year known as allergic rhinitis (AR).
Regional Analysis:
Asia Pacific was the largest market in 2016 and is expected to continue its dominance over the forecast period. The regional market is mainly driven by rising product demand in China, India, Japan, South Korea and Taiwan. Rising awareness regarding chronic nasal problems among consumers of these countries has led to an increase in spending on such products.
In 2016, North America accounted for a significant share owing to high prevalence of rhinitis along with growing consumer awareness about available treatment options for this condition.
Growth Factors:
- Increasing demand for nasal decongestants owing to the growing prevalence of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD)
- Rising awareness about the benefits of oxymetazoline among consumers
- Growing number of product launches by key players in the market
- increasing investments by manufacturers in research and development (R&D) activities to develop new products
- Expansion of distribution channels by manufacturers to increase their reach to consumers
Scope Of The Report
Report Attributes
Report Details
Report Title
Oxymetazoline Market Research Report
By Type
Spray, Cream
By Application
Rhinitis, Sinusitis, Nasal Polyps, Others
By Companies
Complex Pharma, Allergan, Altaire Pharmaceuticals , Health Life of USA, Preferreed Pharmaceuticals , Sheffield Pharmaceuticals, Navajo Manuracturing , Schering Plough, Bayer, Famar Montreal , Perrigo Company, Samson Pharmaceutical, Teva Pharmaceutical Industries
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
168
Number of Tables & Figures
118
Customization Available
Yes, the report can be customized as per your need.
Global Oxymetazoline Market Report Segments:
The global Oxymetazoline market is segmented on the basis of:
Types
Spray, Cream
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Rhinitis, Sinusitis, Nasal Polyps, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Complex Pharma
- Allergan
- Altaire Pharmaceuticals
- Health Life of USA
- Preferreed Pharmaceuticals
- Sheffield Pharmaceuticals
- Navajo Manuracturing
- Schering Plough
- Bayer
- Famar Montreal
- Perrigo Company
- Samson Pharmaceutical
- Teva Pharmaceutical Industries
Highlights of The Oxymetazoline Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Spray
- Cream
- By Application:
- Rhinitis
- Sinusitis
- Nasal Polyps
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oxymetazoline Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oxymetazoline is a medication used to relieve itching. It is available over the counter and in some prescription forms.
Some of the major companies in the oxymetazoline market are Complex Pharma, Allergan, Altaire Pharmaceuticals , Health Life of USA, Preferreed Pharmaceuticals , Sheffield Pharmaceuticals, Navajo Manuracturing , Schering Plough, Bayer, Famar Montreal , Perrigo Company, Samson Pharmaceutical, Teva Pharmaceutical Industries.
The oxymetazoline market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Oxymetazoline Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Oxymetazoline Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Oxymetazoline Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Oxymetazoline Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Oxymetazoline Market Size & Forecast, 2018-2028
4.5.1 Oxymetazoline Market Size and Y-o-Y Growth
4.5.2 Oxymetazoline Market Absolute $ Opportunity
Chapter 5 Global Oxymetazoline Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Oxymetazoline Market Size Forecast by Type
5.2.1 Spray
5.2.2 Cream
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Oxymetazoline Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Oxymetazoline Market Size Forecast by Applications
6.2.1 Rhinitis
6.2.2 Sinusitis
6.2.3 Nasal Polyps
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Oxymetazoline Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Oxymetazoline Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Oxymetazoline Analysis and Forecast
9.1 Introduction
9.2 North America Oxymetazoline Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Oxymetazoline Market Size Forecast by Type
9.6.1 Spray
9.6.2 Cream
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Oxymetazoline Market Size Forecast by Applications
9.10.1 Rhinitis
9.10.2 Sinusitis
9.10.3 Nasal Polyps
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Oxymetazoline Analysis and Forecast
10.1 Introduction
10.2 Europe Oxymetazoline Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Oxymetazoline Market Size Forecast by Type
10.6.1 Spray
10.6.2 Cream
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Oxymetazoline Market Size Forecast by Applications
10.10.1 Rhinitis
10.10.2 Sinusitis
10.10.3 Nasal Polyps
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Oxymetazoline Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Oxymetazoline Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Oxymetazoline Market Size Forecast by Type
11.6.1 Spray
11.6.2 Cream
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Oxymetazoline Market Size Forecast by Applications
11.10.1 Rhinitis
11.10.2 Sinusitis
11.10.3 Nasal Polyps
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Oxymetazoline Analysis and Forecast
12.1 Introduction
12.2 Latin America Oxymetazoline Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Oxymetazoline Market Size Forecast by Type
12.6.1 Spray
12.6.2 Cream
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Oxymetazoline Market Size Forecast by Applications
12.10.1 Rhinitis
12.10.2 Sinusitis
12.10.3 Nasal Polyps
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Oxymetazoline Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Oxymetazoline Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Oxymetazoline Market Size Forecast by Type
13.6.1 Spray
13.6.2 Cream
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Oxymetazoline Market Size Forecast by Applications
13.10.1 Rhinitis
13.10.2 Sinusitis
13.10.3 Nasal Polyps
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Oxymetazoline Market: Competitive Dashboard
14.2 Global Oxymetazoline Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Complex Pharma
14.3.2 Allergan
14.3.3 Altaire Pharmaceuticals
14.3.4 Health Life of USA
14.3.5 Preferreed Pharmaceuticals
14.3.6 Sheffield Pharmaceuticals
14.3.7 Navajo Manuracturing
14.3.8 Schering Plough
14.3.9 Bayer
14.3.10 Famar Montreal
14.3.11 Perrigo Company
14.3.12 Samson Pharmaceutical
14.3.13 Teva Pharmaceutical Industries
